What happened
Matthew Gallagher launched Medvi, a telehealth provider for GLP-1 weight-loss drugs, in September 2024 with US$20,000, using over a dozen AI tools for coding, website copy, ad generation, customer service, and business analytics. Medvi reported US$401 million in sales for 2025 and projects US$1.8 billion (approximately £1.4 billion) in 2026, operating with two employees. The company outsources medical infrastructure to platforms like CareValidate and OpenLoop Health. Medvi's revenue and profits were verified.
Why it matters
AI-driven automation enables founders to achieve rapid business scaling and high revenue with minimal human capital, as Medvi's projected US$1.8 billion in 2026 sales with two employees demonstrates. This shifts unit economics for investors and challenges traditional staffing models for CTOs. Procurement teams must scrutinise AI tool claims, third-party vendor security, and regulatory compliance.
